A 12-months Multi-national, Multi-centre, Double Blind, Randomised, Parallel Safety and Efficacy Comparison of Insulin Detemir Produced by the Current Process and Insulin Detemir Produced by the NN729 Process in Subjects With Type 1 Diabetes on a Basal-bolus Regimen With Insulin Aspart as the Bolus Insulin.
Phase of Trial: Phase III
Latest Information Update: 14 Nov 2014
At a glance
- Drugs Insulin detemir (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 12 Jul 2011 New source identified and integrated (European Clinical Trials Database).
- 23 Jun 2009 Actual patient number (330) added as reported by ClinicalTrials.gov.